 |
|
|
| |
12 Weeks of Daclatasvir in Combination With Sofosbuvir
for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by Black Race
|
| |
| |
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
D Fishbein,1 A Mills,2 Y Zhao,3 S Noviello,3 P Ackerman41MedStar Health Research Institute, Washington DC, DC, USA; 2Southern California Men's Medical Group, Los Angeles, CA, USA; 3Bristol-Myers Squibb, Princeton, NJ, USA; 4Bristol-Myers Squibb, Wallingford, CT, USA.
|
| |
|
|
|
|
|
